A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants
Condition:   Chronic Graft-versus-Host Disease (cGVHD) Interventions:   Drug: AMG 592;   Other: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials

A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
Condition:   Multiple Myeloma Intervention:   Other: No Intervention Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials